Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human COMT ELISA Kit (AC2468)
Cat.#: ASET-1057
Specifications
Description Human COMT ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human COMT concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.095 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 2.5-40 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1653 Human AKAP12 ELISA Kit (AC3064) Quantitative inquiry ASET-2115 Mouse ERK2 ELISA Kit (AC3526) Quantitative inquiry ASET-2260 Mouse LAMP1 ELISA Kit (AC3671) Quantitative inquiry ASET-2218 Human POMT1 ELISA Kit (AC3629) Quantitative inquiry ASET-1621 Mouse PPAR gamma ELISA Kit (AC3032) Quantitative inquiry ASET-1444 Human SorCS1 ELISA Kit (AC2855) Quantitative inquiry ASET-1138 Human LUZP1 ELISA Kit (AC2549) Quantitative inquiry ASET-1028 Mouse FGF1 ELISA Kit (AC2439) Quantitative inquiry ASET-1189 Rat Renalase ELISA Kit (AC2600) Quantitative inquiry ASET-1325 Mouse IL-6 ELISA Kit (AC2736) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket